Found: 9
Select item for more details and to access through your institution.
Correction to: Targeting and Therapeutic Monitoring of H3K27M-Mutant Glioma.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Targeting and Therapeutic Monitoring of H3K27M-Mutant Glioma.
- Published in:
- Current Oncology Reports, 2020, v. 22, n. 2, p. 1, doi. 10.1007/s11912-020-0877-0
- By:
- Publication type:
- Article
P2RY14 cAMP signaling regulates Schwann cell precursor self-renewal, proliferation, and nerve tumor initiation in a mouse model of neurofibromatosis.
- Published in:
- eLife, 2022, p. 1, doi. 10.7554/eLife.73511
- By:
- Publication type:
- Article
Vancomycin and curcumin-loaded zinc oxide functionalized chitosan carrier for the treatment of multi-drug resistant bacterial infection.
- Published in:
- Journal of Materials Science, 2023, v. 58, n. 11, p. 4922, doi. 10.1007/s10853-023-08290-0
- By:
- Publication type:
- Article
TMOD-08. ELUCIDATING EPIGENETIC MECHANISMS IN DIFFUSE INTRINSIC PONTINE GLIOMA HARBORING ACVR1 G328V AND H3.1 K27M.
- Published in:
- Neuro-Oncology, 2019, v. 21, p. ii122, doi. 10.1093/neuonc/noz036.246
- By:
- Publication type:
- Article
GENE-34. MOUSE MODEL OF DIFFUSE INTRINSIC PONTINE GLIOMA HARBORING Acvr1 G328V.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi110, doi. 10.1093/neuonc/noy148.460
- By:
- Publication type:
- Article
Pythium keratitis: clinical course of an emerging scourge.
- Published in:
- 2020
- By:
- Publication type:
- Case Study
Therapeutic targeting of prenatal pontine ID1 signaling in diffuse midline glioma.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 1, p. 54, doi. 10.1093/neuonc/noac141
- By:
- Publication type:
- Article
Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline glioma.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 8, p. 1366, doi. 10.1093/neuonc/noac030
- By:
- Publication type:
- Article